OptimizeRx
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of OptimizeRx generated cash of -$7,239,153, which is less than the previous year. Cash used in financing activities reached the amount of $28,219,789 last year. Net change in cash is therefore -$4,356,229.
Cash Flow
| 2014 | -56.35K | -409.95K | 2.79M |
|---|---|---|---|
| 2015 | 515.11K | -100.96K | 4.34M |
| 2016 | -465.96K | -349.53K | -357.41K |
| 2017 | -1.47M | -42.24K | -390K |
| 2018 | 792.55K | -5.68M | 8.68M |
| 2019 | -1.66M | -10.58M | 22.18M |
| 2020 | -6.31M | -124.72K | -1.90M |
| 2021 | 726.03K | -485.99K | 73.92M |
| 2022 | 10.65M | -58.17M | -18.95M |
| 2023 | -7.23M | -25.33M | 28.21M |
OPRX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 18.20M | 84.68M | 10.51M | 18.85M | 8.91M | 5.12M | 7.03M | 8.20M | 3.44M | 1.11M |
Operating activities | ||||||||||
Net income | -17.56M | -11.43M | 378.07K | -2.20M | -3.14M | 226.34K | -2.10M | -1.53M | -595.14K | -1.02M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.40M | 2.02M | 1.96M | 1.97M | 1.28M | 316.50K | 324.55K | 235.28K | 333.95K | 264.34K |
Stock-based compensation expense | 13.71M | 15.74M | 5.49M | 3.17M | 2.26M | 0 | 87.37K | 175.17K | 327.74K | 899.43K |
| Deferred income tax benefit | 13.71M | 15.74M | 5.49M | 3.17M | 2.26M | 0 | 87.37K | 175.17K | 327.74K | 899.43K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -8.71M | 2.28M | -6.99M | -10.66M | -548.83K | -2.78M | -370.49K | -212.94K | -747.06K | -588.67K |
Inventories | 0 | 0 | -816.58K | -2.20M | -882.47K | -93.21K | 491.07K | 271.08K | -61.00K | -2.86K |
Accounts payable | -1.32M | 555.39K | -603.09K | 3.47M | -336.42K | 647.49K | -909.63K | 60.93K | 864.66K | 226.84K |
Cash generated by operating activities | -7.23M | 10.65M | 726.03K | -6.31M | -1.66M | 792.55K | -1.47M | -465.96K | 515.11K | -56.35K |
Investing activities | ||||||||||
Purchases Of Investments | -162.77M | -55.93M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -87.07K | -244.56K | -485.99K | -124.72K | -1.58M | -91.01K | -42.24K | -349.53K | -100.96K | -409.95K |
Acquisitions Net | -82.94M | -2M | 0 | 0 | -8.99M | -5.59M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -25.33M | -58.17M | -485.99K | -124.72K | -10.58M | -5.68M | -42.24K | -349.53K | -100.96K | -409.95K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 70.67M | 2.48M | 21.30M | 8.16M | 0 | 0 | 4.34M | 8.79M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -7.80M | -20.02M | 0 | 0 | 0 | 0 | -390K | -806.91K | 0 | -6M |
Repayments of term debt | 36.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 28.21M | -18.95M | 73.92M | -1.90M | 22.18M | 8.68M | -390K | -357.41K | 4.34M | 2.79M |
Net Change In Cash | -4.35M | -66.47M | 74.16M | -8.33M | 9.93M | 3.79M | -1.91M | -1.17M | 4.76M | 2.32M |
Cash at end of period | 13.85M | 18.20M | 84.68M | 10.51M | 18.85M | 8.91M | 5.12M | 7.03M | 8.20M | 3.44M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |